Functional Cardiac Lipolysis in Mice Critically Depends on Comparative Gene Identification-58*

Background: The role of CGI-58 in muscle triacylglycerol catabolism is unknown. The presence of CGI-58 increases the lipolytic activity of adipose triglyceride lipase (ATGL). Results: Muscle-specific CGI-58 deficiency causes muscle steatosis and cardiac dysfunction despite elevated ATGL protein expression. Conclusion: Muscle lipolysis critically depends on both CGI-58 and ATGL. Significance: Muscle CGI-58 deficiency provokes severe cardiac steatosis and dysfunction. Efficient catabolism of cellular triacylglycerol (TG) stores requires the TG hydrolytic activity of adipose triglyceride lipase (ATGL). The presence of comparative gene identification-58 (CGI-58) strongly increased ATGL-mediated TG catabolism in cell culture experiments. Mutations in the genes coding for ATGL or CGI-58 in humans cause neutral lipid storage disease characterized by TG accumulation in multiple tissues. ATGL gene mutations cause a severe phenotype especially in cardiac muscle leading to cardiomyopathy that can be lethal. In contrast, CGI-58 gene mutations provoke severe ichthyosis and hepatosteatosis in humans and mice, whereas the role of CGI-58 in muscle energy metabolism is less understood. Here we show that mice lacking CGI-58 exclusively in muscle (CGI-58KOM) developed severe cardiac steatosis and cardiomyopathy linked to impaired TG catabolism and mitochondrial fatty acid oxidation. The marked increase in ATGL protein levels in cardiac muscle of CGI-58KOM mice was unable to compensate the lack of CGI-58. The addition of recombinant CGI-58 to cardiac lysates of CGI-58KOM mice completely reconstituted TG hydrolytic activities. In skeletal muscle, the lack of CGI-58 similarly provoked TG accumulation. The addition of recombinant CGI-58 increased TG hydrolytic activities in control and CGI-58KOM tissue lysates, elucidating the limiting role of CGI-58 in skeletal muscle TG catabolism. Finally, muscle CGI-58 deficiency affected whole body energy homeostasis, which is caused by impaired muscle TG catabolism and increased cardiac glucose uptake. In summary, this study demonstrates that functional muscle lipolysis depends on both CGI-58 and ATGL.

[1]  A. Heerschap,et al.  Increased intramyocellular lipids but unaltered in vivo mitochondrial oxidative phosphorylation in skeletal muscle of adipose triglyceride lipase-deficient mice. , 2012, American journal of physiology. Endocrinology and metabolism.

[2]  Guenter Haemmerle,et al.  FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling , 2012, Cell metabolism.

[3]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[4]  Petra C. Kienesberger,et al.  ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 , 2011, Nature Medicine.

[5]  R. Coleman,et al.  The role of lipid droplets in metabolic disease in rodents and humans. , 2011, The Journal of clinical investigation.

[6]  R. Zechner,et al.  Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores , 2011, Progress in lipid research.

[7]  E. Lewandowski,et al.  Preferential Oxidation of Triacylglyceride-Derived Fatty Acids in Heart Is Augmented by the Nuclear Receptor PPAR&agr; , 2010, Circulation Research.

[8]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[9]  Vidya Subramanian,et al.  CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase , 2010, Journal of Lipid Research.

[10]  L. Orci,et al.  Lipid homeostasis, lipotoxicity and the metabolic syndrome. , 2010, Biochimica et biophysica acta.

[11]  Robert V Farese,et al.  Sirt3 Regulates Fatty Acid Oxidation via Reversible Enzyme Deacetylation Hhs Public Access Supplementary Material , 2022 .

[12]  M. Kumari,et al.  Growth Retardation, Impaired Triacylglycerol Catabolism, Hepatic Steatosis, and Lethal Skin Barrier Defect in Mice Lacking Comparative Gene Identification-58 (CGI-58)* , 2009, The Journal of Biological Chemistry.

[13]  Petra C. Kienesberger,et al.  Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling* , 2009, The Journal of Biological Chemistry.

[14]  R. Zechner,et al.  Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. , 2009, American journal of physiology. Endocrinology and metabolism.

[15]  M. Prentki,et al.  Adipose Triglyceride Lipase Is Implicated in Fuel- and Non-fuel-stimulated Insulin Secretion* , 2009, The Journal of Biological Chemistry.

[16]  R. Eckel,et al.  Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways Published, JLR Papers in Press, November 24, 2008. , 2009, Journal of Lipid Research.

[17]  Z. Arany.  PGC-1 coactivators and skeletal muscle adaptations in health and disease. , 2008, Current opinion in genetics & development.

[18]  R. Rajasekharan,et al.  CGI-58, the Causative Gene for Chanarin-Dorfman Syndrome, Mediates Acylation of Lysophosphatidic Acid* , 2008, Journal of Biological Chemistry.

[19]  Christopher E. Clarke.  A Question of Balance , 2008 .

[20]  T. Pieber,et al.  Validated comprehensive analytical method for quantification of coenzyme A activated compounds in biological tissues by online solid-phase extraction LC/MS/MS. , 2008, Analytical chemistry.

[21]  D. Kelly,et al.  The PPAR trio: regulators of myocardial energy metabolism in health and disease. , 2008, Journal of molecular and cellular cardiology.

[22]  Steven R Smith,et al.  Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. , 2008, American journal of physiology. Endocrinology and metabolism.

[23]  L. Orci,et al.  Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.

[24]  L. Sanderson,et al.  Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling , 2007, PPAR research.

[25]  E. Wagner,et al.  Defective Lipolysis and Altered Energy Metabolism in Mice Lacking Adipose Triglyceride Lipase , 2006, Science.

[26]  Petra C. Kienesberger,et al.  Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. , 2006, Cell metabolism.

[27]  J. Huss,et al.  Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.

[28]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[29]  Andrew N. Carr,et al.  Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. , 2003, The Journal of clinical investigation.

[30]  R. Zechner,et al.  Hormone-sensitive Lipase Deficiency in Mice Changes the Plasma Lipid Profile by Affecting the Tissue-specific Expression Pattern of Lipoprotein Lipase in Adipose Tissue and Muscle* , 2002, The Journal of Biological Chemistry.

[31]  R. Zechner,et al.  Hormone-sensitive Lipase Deficiency in Mice Causes Diglyceride Accumulation in Adipose Tissue, Muscle, and Testis* , 2002, The Journal of Biological Chemistry.

[32]  J. Weissenbach,et al.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. , 2001, American journal of human genetics.

[33]  N. Yahagi,et al.  Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[35]  Robert V Farese,et al.  Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[37]  I. Chanarin,et al.  Neutral-lipid storage disease: a new disorder of lipid metabolism. , 1975, British medical journal.

[38]  L. Bieber,et al.  A rapid spectrophotometric assay for carnitine palmitoyltransferase. , 1972, Analytical biochemistry.

[39]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[40]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[41]  Robert V Farese,et al.  SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .

[42]  M. Lathrop,et al.  The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy , 2007, Nature Genetics.

[43]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[44]  E. Van Obberghen,et al.  [Mechanisms of insulin resistance]. , 1989, Journees annuelles de diabetologie de l'Hotel-Dieu.

[45]  M. Markwell,et al.  Peroxisomal and microsomal carnitine acetyltransferases. , 1981, Methods in enzymology.

[46]  M. Markwell,et al.  [42] Peroxisomal and microsomal carnitine acetyltransferases: EC 2.3.1.7 acetyl-CoA:carnitine O-acetyltransferase , 1981 .